Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

A sharper Bonferroni procedure for multiple tests of significance

1988 • 4,545 citations

Clozapine for the Treatment-Resistant Schizophrenic

1988 • 4,030 citations

Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis

1999 • 2,382 citations

Practical Clinical Trials

2003 • 1,686 citations

Discovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic Imperative

2004 • 1,429 citations

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

2000 • 1,079 citations

A Meta-analysis of the Efficacy of Second-Generation Antipsychotics

2003 • 1,008 citations

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

2004 • 948 citations

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1999 • 807 citations

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

2003 • 730 citations

The Effects of Atypical Antipsychotic Drugs on Neurocognitive Impairment in Schizophrenia: A Review and Meta-analysis

1999 • 698 citations

The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development

2003 • 634 citations

Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials

2001 • 631 citations

Relapse Prevention in Schizophrenia With New-Generation Antipsychotics: A Systematic Review and Exploratory Meta-Analysis of Randomized, Controlled Trials

2003 • 501 citations

Evidence of Clozapine’s Effectiveness in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Trials

1999 • 357 citations

Dose Response and Dose Equivalence of Antipsychotics

2004 • 348 citations

Glucose Metabolism in Patients With Schizophrenia Treated With Atypical Antipsychotic Agents

2005 • 320 citations

Effectiveness and Cost of Olanzapine and Haloperidol in the Treatment of Schizophrenia<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2003 • 314 citations

Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine

1997 • 302 citations

Depressive Signs and Symptoms in Schizophrenia

1998 • 264 citations

An Assessment of the Independent Effects of Olanzapine and Risperidone Exposure on the Risk of Hyperlipidemia in Schizophrenic Patients

2002 • 239 citations

Dropout rates in randomised antipsychotic drug trials

2001 • 167 citations

Neurocognitive Assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project Schizophrenia Trial: Development, Methodology, and Rationale

2003 • 115 citations

Assessing Clinical and Functional Outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial

2003 • 108 citations

Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials

2002 • 103 citations

Optimal Dosing of Atypical Antipsychotics in Adults: A Review of the Current Evidence

2002 • 90 citations

Open Forum: Effectiveness Versus Efficacy of Second-Generation Antipsychotics: Haloperidol Without Anticholinergics as a Comparator

2005 • 54 citations

Statistical Approaches to Effectiveness Measurement and Outcome-Driven Re-Randomizations in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Studies

2003 • 44 citations

Changing Environments and Alternative Perspectives in Evaluating the Cost-Effectiveness of New Antipsychotic Drugs

2003 • 18 citations

Approaches to Multisite Clinical Trials: The National Institute of Mental Health Perspective

2003 • 14 citations